Добавить в папку Экспорт Добавить в избранное Добавить в архив

Холдинг
ID ...... Расширение производства лекарственного препарата

А
  • Дата добавления

    26.04.2021
  • Последнее обновление

    28.06.2022
  • Краткое описание

    Крупная фармацевтическая компания собирается увеличить производство лекарственного препарата антикоагулянта. Сейчас обсуждаются различные варианты его воплощения
  • Полное описание

    ················ ················ ············ ················ ············ ···· ········ ······ ······ ···· ················ ················ ········ ················ ······ ·········· ·············· ······ ···· ·········· ············ ············ ·········· ······ ·············· ·········· ·············· ················ ·········· ···· ·········· ············ ·············· ······ ········ ············ ···· ················
  • Результаты интервью

    ···· ·················· ···· ····.····.········ ········ ·········· ·················· ······ ············ ···· ···················· ························ ·················· ·············· ············ ·················· ·· ············ ······················

    ···· ·················· ···· ····.····.········ ········ ·········· ·················· ······ ················ ·················· ·· ···················· ················ ············ ······················ ···· ········ ·········· ···· ············ ············ ······ ·················· ················

    ···· ·················· ···· ····.····.········ ························ ·············· ····················

  • Объем инвестиций

    ········ ··········
  • Холдинг инвестора

    ················ ···· ········ ············
    Активные — ···· ················ руб, 1 проект

Прогноз расхода материала

Материал
Стадия проекта

Инвестор

+ 7

Генеральный проектировщик

Генеральный подрядчик

Портал инвестиционных проектов России <http://investprojects.info/projects/newmy?project_id=73458>
Вся информация, размещенная на данном веб-сайте, предназначена только для персонального пользования и не подлежит дальнейшему воспроизведению и / или распространению в какой-либо форме, иначе как с письменного разрешения Инвестиционной группы "Профессиональные Комплексные Решения" (ПКР)
Показать